![](/img/cover-not-exists.png)
Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells
Boudny, Miroslav, Zemanova, Jana, Khirsariya, Prashant, Borsky, Marek, Verner, Jan, Cerna, Jana, Oltova, Alexandra, Seda, Vaclav, Mraz, Marek, Jaros, Josef, Jaskova, Zuzana, Spunarova, Michaela, BrychLanguage:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2018.203430
Date:
April, 2019
File:
PDF, 2.26 MB
english, 2019